Filing Flows › AstraZeneca (AZN) › Q2 2025 › vs Q2 2024
AstraZeneca (AZN) Q2 2025 vs Q2 2024 (year over year)
AstraZeneca's revenue rose $1.5B (+12%) from $12.9B in Q2 2024 to $14.5B in Q2 2025. Gross margin 82.9% against 83.1% (-0.2 pts).
AstraZeneca, Q2 2025: revenue $14.5B (+12% year over year), operating margin 24.3%, net earnings $2.4B. The chart draws each line against Q2 2024, the increases inside each band.
Margins
| Q2 2025 | Q2 2024 | Change | |
|---|---|---|---|
| Gross margin | 82.9% | 83.1% | -0.2 pts |
| Operating margin | 24.3% | 21.2% | +3.0 pts |
| Net margin | 16.9% | 14.9% | +2.0 pts |
Every line
| Line | Q2 2025 | Q2 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $14.5B | $12.9B | $1.5B | +12% |
| Gross profit | $12.0B | $10.8B | $1.2B | +11% |
| Cost of revenue | $2.5B | $2.2B | $290M | +13% |
| Operating profit | $3.5B | $2.7B | $762M | +28% |
| Operating expenses | $8.5B | $8.0B | $467M | +6% |
| Pre-tax earnings | $3.1B | $2.4B | $730M | +30% |
| Other expense, net | $381M | $349M | $32.0M | +9% |
| Research & development | $3.5B | $3.0B | $540M | +18% |
| SG&A | $4.9B | $4.9B | −$65.0M | -1% |
| Other operating costs | $64.0M | $72.0M | −$8.0M | -11% |
| Net earnings | $2.4B | $1.9B | $520M | +27% |
| Income tax | $679M | $469M | $210M | +45% |
Questions
How much did AstraZeneca's revenue grow year over year in Q2 2025?
AstraZeneca's revenue rose $1.5B (+12%) from $12.9B in Q2 2024 to $14.5B in Q2 2025. Gross margin 82.9% against 83.1% (-0.2 pts).